Open AccessStem cell translational medicine: The Tianjin model revisited
Author(s) -
Chen Haidan
Publication year - 2021
Publication title -
stem cells translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.781
H-Index - 71
eISSN - 2157-6580
pISSN - 2157-6564
DOI - 10.1002/sctm.20-0494
Subject(s) - translational medicine , enthusiasm , translational research , stem cell , stem cell therapy , process (computing) , strengths and weaknesses , cell therapy , translational science , medicine , computer science , biology , psychology , pathology , microbiology and biotechnology , social psychology , operating system
Stem cells hold great promise for cell therapy to treat a wide spectrum of intractable diseases. Despite enthusiasm for stem cell therapy, the clinical and translational research of stem cells overall has been a slow and cumbersome process. This article uses the “technological system” as a framework to analyze the Tianjin model of stem cell translational medicine. It shows how heterogeneous elements interact with one another and relate to scientific, technological, social, economic, and political variables in order to fulfill the system goal of producing cell therapy in China. Then the strengths and weaknesses of the Tianjin model are compared with translational programs in other countries and the implications for the cell therapy industry are discussed.